scholarly journals The pancreas as a target of metastasis from renal cell carcinoma: Results of surgical treatment in a single institution

2019 ◽  
Vol 23 (3) ◽  
pp. 240
Author(s):  
Juan Glinka ◽  
Rodrigo Sanchez Claria ◽  
Victoria Ardiles ◽  
Eduardo de Santibañes ◽  
Juan Pekolj ◽  
...  
2011 ◽  
Vol 2011 ◽  
pp. 1-4 ◽  
Author(s):  
Jasper Decoene ◽  
Filip Ameye ◽  
Evelyne Lerut ◽  
Raymond Oyen ◽  
Hein Van Poppel ◽  
...  

Renal cell carcinomas (RCCs) are known for their unpredictable metastatic pattern. We present the case of a 63-year-old woman who initially presented in 1992 with a metastasis in the left calcaneus that led to the discovery of RCC. In 1998, a new metastasis was found in the ovary. In 2008, the diagnosis of a gallbladder metastasis was made. All metastases were surgically removed; no additional systemic therapies were used. Aggressive surgical treatment can prolong the survival of patients with resectable metastases. Patterns of metastasis are discussed, and a brief review of the literature is given regarding each localization.


2002 ◽  
Vol 41 (3) ◽  
pp. 262-266 ◽  
Author(s):  
N. Melissourgos ◽  
K. Doumas ◽  
I. Messini ◽  
E. Papaliodi ◽  
N.G. Kastrinakis ◽  
...  

2018 ◽  
Vol 26 (3) ◽  
pp. 385-390 ◽  
Author(s):  
Sebastian K Frees ◽  
Mohammed M Kamal ◽  
Sebastian Nestler ◽  
Patrick MF Levien ◽  
Samir Bidnur ◽  
...  

1999 ◽  
Vol 162 (4) ◽  
pp. 1402-1405 ◽  
Author(s):  
HIROSHI ASANUMA ◽  
HIDEO NAKAI ◽  
MASASHI TAKEDA ◽  
SEIICHIRO SHISHIDO ◽  
EIJI TAJIMA ◽  
...  

2018 ◽  
Vol 14 (2) ◽  
pp. 68-78 ◽  
Author(s):  
B. Ya. Alekseev ◽  
I. M. Shevchuk ◽  
A. D. Kaprin

Renal cell carcinoma (RCC) is one of the most common genitourinary malignancies worldwide. Approximately 25–30 % of newly diagnosed patients have metastatic RCC (mRCC), whereas in 20–30 % of cases, dissemination occurs after radical surgical treatment. The development of targeted and immunooncological agents in recent years significantly increased survival in patients with mRCC. However, clinicians faced a problem of choosing an optimal therapeutic regimen to achieve maximum effectiveness of the treatment. This article discusses the choice of second-line drugs for mRCC, advantages of axitinib and its optimal dosage, and efficacy of sunitinib depending on the disease prognosis.


2018 ◽  
Vol 17 (2) ◽  
pp. e610
Author(s):  
P. Capogrosso ◽  
F. Muttin ◽  
A. Larcher ◽  
D. Sjoberg ◽  
E. Vertosick ◽  
...  

2013 ◽  
pp. 235-394 ◽  
Author(s):  
John Reynard ◽  
Simon Brewster ◽  
Suzanne Biers

Basic pathology and molecular biology 236 Wilms’ tumour and neuroblastoma 238 Radiological assessment of renal masses 242 Benign renal masses 244 Renal cell carcinoma: pathology, staging, and prognosis 246 Renal cell carcinoma: epidemiology and aetiology 250 Renal cell carcinoma: presentation and investigation 252 Renal cell carcinoma (localized): surgical treatment I ...


2019 ◽  
Vol 18 (1) ◽  
pp. e1419-e1420
Author(s):  
P. Capogrosso ◽  
A. Larcher ◽  
F. Cianflone ◽  
F. Muttin ◽  
F. Trevisani ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document